BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31412224)

  • 1. PROGNOSIS OF DIFFERENTIATED THYROID CARCINOMA IN PATIENTS WITH GRAVES DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Mekraksakit P; Rattanawong P; Karnchanasorn R; Kanitsoraphan C; Leelaviwat N; Poonsombudlert K; Kewcharoen J; Dejhansathit S; Samoa R
    Endocr Pract; 2019 Dec; 25(12):1323-1337. PubMed ID: 31412224
    [No Abstract]   [Full Text] [Related]  

  • 2. Features and outcome of differentiated thyroid carcinoma associated with Graves' disease: results of a large, retrospective, multicenter study.
    Premoli P; Tanda ML; Piantanida E; Veronesi G; Gallo D; Masiello E; Rosetti S; Cusini C; Boi F; Bulla J; Rodia R; Mariotti S; Capelli V; Rotondi M; Magri F; Chiovato L; Rocchi R; Campopiano MC; Elisei R; Vitti P; Barbato F; Pilli T; Castagna MG; Pacini F; Bartalena L
    J Endocrinol Invest; 2020 Jan; 43(1):109-116. PubMed ID: 31327128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased mortality in patients with differentiated thyroid cancer associated with Graves' disease.
    Pellegriti G; Mannarino C; Russo M; Terranova R; Marturano I; Vigneri R; Belfiore A
    J Clin Endocrinol Metab; 2013 Mar; 98(3):1014-21. PubMed ID: 23348395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease Burden and Outcome in Children and Young Adults With Concurrent Graves Disease and Differentiated Thyroid Carcinoma.
    MacFarland SP; Bauer AJ; Adzick NS; Surrey LF; Noyes J; Kazahaya K; Mostoufi-Moab S
    J Clin Endocrinol Metab; 2018 Aug; 103(8):2918-2925. PubMed ID: 29788090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidental papillary thyroid carcinoma: clinical characteristics and prognostic factors among patients with Graves' disease and euthyroid goiter, Cleveland Clinic experience.
    Ergin AB; Saralaya S; Olansky L
    Am J Otolaryngol; 2014; 35(6):784-90. PubMed ID: 25128909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Incidental differentiated thyroid carcinoma is less prevalent in Graves' disease than in multinodular goiter].
    Pascual Corrales E; Príncipe RM; Laguna Muro S; Martínez Regueira F; Alcalde Navarrete JM; Guillén Grima F; Galofré JC
    Endocrinol Nutr; 2012 Mar; 59(3):169-73. PubMed ID: 22325789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Graves' disease on the prognosis of differentiated thyroid carcinoma: a meta-analysis.
    Song Y; Fu L; Wang P; Sun N; Qiu X; Li J; Zheng S; Ren S; Ding X; Li L; Du J; Wang C; Jiao Z; Zhao W
    Endocrine; 2020 Mar; 67(3):516-525. PubMed ID: 31637658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of papillary thyroid cancer in patients with Graves' disease: a propensity score-matched analysis.
    Kwon H; Moon BI
    World J Surg Oncol; 2020 Oct; 18(1):266. PubMed ID: 33050937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and pathological differences between papillary thyroid carcinoma with Graves' disease and papillary thyroid carcinoma with Hashimoto's thyroiditis].
    Xu DD; Lun Y; Liu X; Jiang H; Song JB; Duan ZQ; Xin SJ; Zhang J
    Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(32):2491-2495. PubMed ID: 28835054
    [No Abstract]   [Full Text] [Related]  

  • 10. Higher incidence of tall cell variant of papillary thyroid carcinoma in Graves' Disease.
    Boutzios G; Vasileiadis I; Zapanti E; Charitoudis G; Karakostas E; Ieromonachou P; Karatzas T
    Thyroid; 2014 Feb; 24(2):347-54. PubMed ID: 23786233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics, staging and outcomes of differentiated thyroid cancer in patients with and without Graves' disease.
    Gopinath C; Crow H; Panthi S; Bantis L; Burman KD; Choudhary C
    J Clin Transl Endocrinol; 2023 Sep; 33():100321. PubMed ID: 37547825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, Pathological, and Molecular Characteristics Correlating to the Occurrence of Radioiodine Refractory Differentiated Thyroid Carcinoma: A Systematic Review and Meta-Analysis.
    Luo Y; Jiang H; Xu W; Wang X; Ma B; Liao T; Wang Y
    Front Oncol; 2020; 10():549882. PubMed ID: 33117686
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence and aggressiveness of papillary thyroid carcinoma in surgically-treated graves' disease patients: a retrospective matched cohort study.
    You E; Mascarella MA; Al Jassim A; Forest VI; Hier MP; Tamilia M; Pusztaszeri M; Payne RJ
    J Otolaryngol Head Neck Surg; 2019 Aug; 48(1):40. PubMed ID: 31462328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between thyroid peroxidase antibody and differentiated thyroid cancer: a systematic review and meta-analysis.
    Zhang H; Tian L; Wang X; Shi X
    Front Endocrinol (Lausanne); 2024; 15():1349041. PubMed ID: 38476675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors of Lymphnode Metastasis in Patients with Thyroid Papillary Carcinoma Associated with Graves Disease.
    Xie Y; Liu YW; Wang MY; Wang WZ; Liu HF; Li XY; Gao WS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):554-558. PubMed ID: 27825413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological Risk Factors for Distant Metastasis in Differentiated Thyroid Carcinoma: A Meta-analysis.
    Vuong HG; Duong UNP; Pham TQ; Tran HM; Oishi N; Mochizuki K; Nakazawa T; Hassell L; Katoh R; Kondo T
    World J Surg; 2018 Apr; 42(4):1005-1017. PubMed ID: 28913696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
    Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
    Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.
    Lundgren CI; Hall P; Dickman PW; Zedenius J
    Cancer; 2006 Feb; 106(3):524-31. PubMed ID: 16369995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DEATH RELATED TO PULMONARY METASTASIS IN PATIENTS WITH DIFFERENTIATED THYROID CANCER.
    Leite AK; Kulcsar MA; de Godoi Cavalheiro B; de Mello ES; Alves VA; Cernea CR; Matos LL
    Endocr Pract; 2017 Jan; 23(1):72-78. PubMed ID: 27749128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilaterality weighs more than unilateral multifocality in predicting prognosis in papillary thyroid cancer.
    Qu N; Zhang L; Wu WL; Ji QH; Lu ZW; Zhu YX; Lin DZ
    Tumour Biol; 2016 Jul; 37(7):8783-9. PubMed ID: 26743781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.